Language: Spanish
References: 8
Page: 176-178
PDF size: 195.16 Kb.

REFERENCES

1. Grace E, Asbill S, Virga K. Naegleria fowleri: pathogenesis, diagnosis, and treatment options. Antimicrob Agents Chemother. 2015; 59 (11): 6677-6681.

2. Jahangeer M, Mahmood Z, Munir N, Waraich UE, Tahir IM, Akram M et al. Naegleria fowleri: sources of infection, pathophysiology, diagnosis, and management; a review. Clin Exp Pharmacol Physiol. 2020; 47 (2):199-212.

3. Taravaud A, Fechtali-Moute Z, Loiseau PM, Pomel S. Drugs used for the treatment of cerebral and disseminated infections caused by free-living amoebae. Clin Transl Sci. 2021; 14: 791-805.

4. CDC. Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division of Foodborne, Waterborne, and Environmental Diseases (DFWED). 2022.

5. Alexeieff A. Sur les caracteres cytologiques et la systematique des amibes du groupe limax (Naegleria nov. gen. et Hartmannia nov. gen.) et des amibes parasites des vertébrés (Proctamoeba nov. gen.). Bull Soc Zool. 1912; 37: 55-74.

6. Carter RF. Description of a Naegleria sp. isolated from two cases of primary amoebic meningo-encephalitis, and of the experimental pathological changes induced by it. J Pathol. 1970; 100 (4): 217-244.

7. Vargas-Zepeda J, Gomez-Alcala AV, Vasquez-Morales JA, Licea-Amaya L, De Jonckheere JF, Lares-Villa F. Successful treatment of Naegleria fowleri meningoencephalitis by using intravenous amphotericin B, fluconazole and rifampicin. Arch Med Res. 2005; 36: 83-86.

8. Maciver SK, Piñero JE, Lorenzo-Morales J. Is Naegleria fowleri an emerging parasite? Trends Parasitol. 2020; 36 (1): 19-28.